![Nancy Lurker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nancy Lurker
Directeur/Membre du Conseil chez
EYEPOINT, INC.
Fortune : 7 M $ au 31/05/2026
Profil
Nancy Sue Lurker is Executive Vice Chairman at EyePoint, Inc. since 2023.
Director at Altasciences Co., Inc. since 2021.
Independent Director at Alkermes Plc since 2024.
Independent Director at Collegium Pharmaceutical, Inc. since 2025.
Director at NSF International (Michigan) since 2024.
Former President, Chief Executive Officer & Director at Interpace Biosciences, Inc. from 2011 to 2015.
Former President & Chief Executive Officer at ImpactRx, Inc. from 2003 to 2006.
Former President, Chief Executive Officer & Director at Pdi, Inc. (United States) from 2008 to 2015.
Former Chairman at X4 Pharmaceuticals, Inc. from 2016 to 2018.
Former Senior Director-Worldwide Cardiovascular Franchise at Bristol Myers Squibb Co. in 1998.
Former Director at Elan Corp.
Plc from 2005 to 2006.
Former Independent Director at Auxilium Pharmaceuticals LLC from 2011 to 2015.
Former Director at Elan Pharmaceuticals LLC in 2006.
Former Independent Director at Aquestive Therapeutics, Inc. from 2018 to 2022.
Former Independent Director at Keenova Therapeutics PLC from 2013 to 2016.
Former Director at ConjuChem Biotechnologies, Inc. in 2006.
Former Director at Cancer Treatment Centers of America, Inc. from 2016 to 2020.
Former Vice President-Global Primary Care Products Group at Pharmacia Corp.
in 2003.
Former Chief Marketing Officer & Senior Vice President at Novartis Pharmaceuticals Corp.
from 2006 to 2007.
Former Vice President-Business Development at National Physicians Corp.
Education includes undergraduate degree from Seattle Pacific University and MBAistration from the University of Evansville.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EYEPOINT, INC. 0,5% | 21/04/2026 | 421 235 ( 0,5% ) | 6 M $ | 31/05/2026 |
| 21/05/2026 | 18 222 ( 0,01% ) | 768 786 $ | 31/05/2026 | |
| 14/05/2026 | 18 017 ( 0,06% ) | 605 551 $ | 31/05/2026 |
Postes actifs de Nancy Lurker
| Sociétés | Poste | Début |
|---|---|---|
| EYEPOINT, INC. | Directeur/Membre du Conseil | 15/09/2016 |
| ALKERMES PLC | Directeur/Membre du Conseil | 07/03/2024 |
| COLLEGIUM PHARMACEUTICAL, INC. | Directeur/Membre du Conseil | 04/02/2025 |
Altasciences Co., Inc.
 Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Offers contract research organization and early-phase drug development & preclinical safety testing services | Directeur/Membre du Conseil | 01/04/2021 |
NSF International ( Michigan)
 NSF International ( Michigan) Miscellaneous Commercial ServicesCommercial Services Operates as an organization for public health standards | Directeur/Membre du Conseil | 01/01/2024 |
Anciens postes connus de Nancy Lurker
| Sociétés | Poste | Fin |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 22/06/2022 |
Cancer Treatment Centers of America, Inc.
 Cancer Treatment Centers of America, Inc. Hospital/Nursing ManagementHealth Services Operates cancer treatment hospitals | Directeur/Membre du Conseil | 01/01/2020 |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and distributes oral small molecule CXCR4 antagonists | Président | 01/01/2018 |
| MALLINCKRODT PLC | Directeur/Membre du Conseil | 21/07/2016 |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Nancy Lurker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Interpace Biosciences, Inc.
 Interpace Biosciences, Inc. Medical SpecialtiesHealth Technology Provides commercialization services to biopharmaceutical companies | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
ImpactRx, Inc.
 ImpactRx, Inc. Miscellaneous Commercial ServicesCommercial Services Provides health-care sector custom research and promotional consultancy services | Commercial Services |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
NSF International ( Michigan)
NSF International ( Michigan) Miscellaneous Commercial ServicesCommercial Services Operates as an organization for public health standards | Commercial Services |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and distributes oral small molecule CXCR4 antagonists | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Seattle Pacific University
 Seattle Pacific University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Evansville
 University of Evansville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Cancer Treatment Centers of America, Inc.
Cancer Treatment Centers of America, Inc. Hospital/Nursing ManagementHealth Services Operates cancer treatment hospitals | Health Services |
National Physicians Corp. | |
ConjuChem Biotechnologies, Inc.
 ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Develops peptide based pharmaceuticals | Health Technology |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Altasciences Co., Inc.
Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Offers contract research organization and early-phase drug development & preclinical safety testing services | Commercial Services |
Pdi, Inc. (United States) | Commercial Services |
